Review
LONGER-ACTING DRUG DELIVERY SYSTEMS FOR DIABETIC RETINOPATHY
Author(s): Nisha Rajendra Gawali, Prashant Lakshaman Pingale*, Dattatray Manohar Shinkar, Sahebrao Sampat Boraste and Sunil Vishvnath Amrutkar
Diabetic retinopathy (DR) is characterized by harm to the retinal blood vessels, which ultimately results in visual loss. Diseases that affect the posterior segment of the eye, such as cytomegalovirus retinitis, posterior uveitis, age-related macular degeneration, and diabetic retinopathy, necessitate the development of a novel delivery system that can increase the level of drug that reaches the posterior segment of the eye. The current therapies for DR are intrusive, costly, and time-consuming. The creation of innovative medication delivery systems has gained prominence in the area of research, with nanotechnology being the much heavily explored option. As a novel formulation for drug delivery, Nanoparticles, nanoliposomes, niosomes, nanomicelles, nanoemulsions, nanogels, cyclodextrins, dendrimers, and quantum dots are among the nanotechnology-based systems being developed. The logic.. Read More»
DOI:
10.4172/0975-413X.15.1.1-6
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report